A Novel Model of IVIG Immunosuppression: Activation of Natural Regulatory T cells by IgG-Derived Peptides
Laurence Van Overvelt , Paul M Knopf , Erik Wambre , Philippe Moingeon
The FASEB Journal 22
2008
Standardization, sensitivity and specificity of an ash (Fraxinus excelsior) pollen allergen extract
Agnès Viatte , Philippe Moingeon , Robert K. Zeldin , Ashok Purohit
European Respiratory Journal 40 2337
2012
Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen Ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colony- stimulating factor induced a tumor-specific cellular immune response.
Gustav J Ullenhag , Philippe Moingeon , Håkan Mellstedt , Moustapha Hassan
Clinical Cancer Research 9 ( 7) 2447 -2456
59
2003
Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccine.
Peter J. K. Kuppen , Rob A. E. M. Tollenaar , Rienk Offringa , Sjoerd H. van der Burg
Clinical Cancer Research 8 ( 5) 1019 -1027
88
2002
Adjuvants and vector systems for the sublingual route.
Thierry Batard , Laurent Mascarell , Sabi Airouche , Véronique Bodo
Arbeiten aus dem Paul-Ehrlich-Institut (Bundesinstitut fur Impfstoffe und biomedizinische Arzneimittel) Langen/Hessen 97 164 -167
1
2013
Clinical trials with allergen products: in search of biological markers of efficacy.
Philippe Moingeon
Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M ( 95) 182
1
2006
Validation of quantitative, allergen-specific ELISAs.
Stefan Vieths , Carlo Pini , Helmut Fiebig , Monika Raulf-Heimsoth
Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M ( 95) 91
5
2006
Les vaccins thérapeutiques : L'arsenal biotech contre les cancers
Philippe Moingeon
Biofutur ( 212) 54 -57
2001
Les vaccins du futur
Claude Leclerc , Philippe Moingeon
Biofutur 217 82 -86
2001
Structural and functional characterization of the cysteine protease Amb a 11, a new major allergen from short ragweed (Ambrosia artemisiifolia) pollen
V. Baron-Bodo , M. Le Mignon , Nathalie Berjont , Véronique Bordas-Le Floch
Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology 71 1
2016
S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases.
Emmanuel Nony , Adrian C. Hayday , Philippe Moingeon , Kai Kisand
Journal of translational autoimmunity 4 100093 -100093
2021
Proliferative responses of circulating human NK cells: delineation of a unique pathway involving both direct and helper signals
Arnaucl Ythier , Laurence Delmon , Ellis Reinherz , Alexandra Nowill
European Journal of Immunology 15 ( 12) 1209 -1215
14
1985
Lactic acid bacteria as adjuvants for sublingual allergy vaccines.
Laurence Van Overtvelt , Helene Moussu , Stéphane Horiot , Sandrine Samson
Vaccine 28 ( 17) 2986 -2992
54
2010
Inhibition of acetylcholinesterase and cholinesterase by ellipticine derivatives
Gilles F. Alberici , Jean-Michel Bidart , Philippe Moingeon , Jean-Marc Mondesir
Biochemical Pharmacology 32 ( 18) 2837 -2839
4
1983
Ellipticine derivatives interact with muscarinic receptors.
Gilles F. Alberici , Jean-Michel Bidart , Philippe Moingeon , Sylvie Pailler
Biochemical Pharmacology 34 ( 10) 1701 -1704
6
1985
Comparative analysis of the oral mucosae from rodents and non-rodents: Application to the nonclinical evaluation of sublingual immunotherapy products.
Catherine Thirion-Delalande , Frédéric Gervais , Cécile Fisch , Jean Cuiné
PLOS ONE 12 ( 9)
15
2017
Allergen extracts for immunotherapy: to mix or not to mix?
Emmanuel Nony , Armelle Martelet , Karine Jain , Philippe Moingeon
Expert Review of Clinical Pharmacology 9 ( 3) 401 -408
2
2016
A dynamic COVID-19 immune signature includes associations with poor prognosis.
Adam G. Laing , Anna Lorenc , Irene del Molino del Barrio , Abhishek Das
Nature Medicine 26 ( 10) 1623 -1635
728
2020
Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy.
Thierry Batard , Alain Didierlaurent , Henri Chabre , Nadine Mothes
International Archives of Allergy and Immunology 136 ( 3) 239 -249
50
2005
Generation of monoclonal antibodies blocking cytotoxic reactions by human NK clones: Further characterization of a 4080-kDa target cell receptor
Arnaud Ythier , Philippe Moingeon , Marina Fabbi , Laurence Delmon
Cellular Immunology 99 ( 1) 150 -159
6
1986